"Designing Growth Strategies is in our DNA"

Veterinary Artificial Insemination Market Size, Share & Industry Analysis, By Product (Equipment, Kits & Consumables, and Others), By Animal Type (Bovine, Swine, Ovine & Caprine, Equine, and Others), By End-user (Livestock Farms/Commercial Animal Farms, Animal Breeding Centers & Semen Stations, and Others), and Regional Forecast, 2026-2034

Last Updated: June 04, 2026 | Format: PDF | Report ID: FBI116924

 

Veterinary Artificial Insemination Market Size and Future Outlook

Play Audio Listen to Audio Version

The global veterinary artificial insemination market size was valued at USD 3.60 billion in 2025. The market is projected to grow from USD 3.84 billion in 2026 to USD 6.65 billion by 2034, exhibiting a CAGR of 7.1% during the forecast period.

Veterinary artificial insemination is the controlled placement of semen into the reproductive tract of livestock or companion animals without natural mating. It is widely used in cattle, swine, equine, sheep, goats, and, increasingly, in canine breeding to improve genetics, manage breeding timing, reduce disease transmission risks, and support higher productivity. The market growth is attributed to rising demand for milk, meat, and high-value animal genetics, along with wider adoption of frozen semen and sex-sorted semen.

Key players in the market include ABS Global, Select Sires Inc., and STgenetics. The dominance of these players is attributed to their focus on advanced reproductive technologies such as sexed semen, cryopreservation, AI catheters, and hormone synchronization tools. Also, they are increasing focus on technician training programs and local insemination support to enhance their market position.

Integration of AI With Digital Fertility Monitoring and Decision-Support Tools to Emerge as a Key Trend

Currently, there has been a significant shift from basic insemination services toward integrated reproductive management using ultrasound, fertility analytics, genomic selection, and AI-based decision support. As a result, key market players are launching advanced technologies for artificial insemination to meet the growing demand for precision reproduction solutions. Moreover, researchers are also focused on the introduction of novel technologies to enhance this scenario further.

  • For instance, in March 2024, IMV Technologies Group launched BovIntel in the U.K. and France to automatically identify and measure ovarian structures on ultrasound images in real time, supporting veterinarians during fertility scanning.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Use of Sexed Semen and Genetic Improvement Programs to Fuel Market Expansion

Over the past few years, the use of sexed semen and superior genetics has increased globally to improve herd productivity and profitability. Dairy farmers are using sexed semen to generate more female calves from high-performing cows, while beef-on-dairy programs are helping improve calf value. This is expected to boost the strong adoption of reproductive technologies that help producers control offspring sex, improve replacement planning, and increase economic returns. Such a scenario is anticipated to drive the global veterinary artificial insemination market growth.

  • For instance, the 2024 National Association of Animal Breeders (NAAB) semen sales report showed gender-sorted dairy units increased by 1.5 million units, or 18.0%, reaching over 9.9 million units in the U.S. dairy market.

MARKET RESTRAINTS

High Costs and Limited Access to Skilled AI Professionals May Hamper Market Growth

Despite the strong benefits of artificial insemination, the market growth is restrained by the need for trained inseminators, liquid nitrogen storage, accurate heat detection, semen handling infrastructure, and good farm-level management. Moreover, poor timing, low semen quality, incorrect thawing, and inadequate technician skill can reduce conception rates and discourage adoption among small farmers. Furthermore, in several regions, limited access to quality semen and trained personnel is expected to slow adoption even when demand for productivity improvement is high. This is expected to hamper the market growth in the forthcoming years.

  • For instance, according to the data from MARS Veterinary Health, despite projected increases in the number of new veterinary graduates over the coming decade, experts anticipate a persistent shortfall of as many as 24,000 companion-animal veterinarians by 2030.

MARKET OPPORTUNITIES

Expansion of Sex-Sorted Semen Labs and AI Infrastructure in Emerging Dairy Markets to Create Lucrative Growth Opportunities

In developing regions, governments, cooperatives, and breeding companies are increasingly investing in semen production, sex-sorted semen, and AI coverage, which is expected to create strong opportunities for artificial insemination products.

  • For instance, in August 2025, Rajasthan’s first sex-sorted semen lab was inaugurated in Bassi with support from the National Dairy Development Board to produce a large volume of semen doses annually.

Such initiatives are expanding access to high-quality germplasm, improving breed development, and supporting milk productivity growth. Similarly, public-private breeding infrastructure models are expected to create new demand for semen straws, AI guns, cryostorage systems, and fertility scanners.

MARKET CHALLENGES

Variable Conception Outcomes and Supply Limitations for Advanced Semen Products to Challenge Market Expansion

In several countries, achieving consistent conception rates across farms, species, and breeds has been challenging as advanced products such as sex-sorted semen may require better timing, healthier animals, precise semen handling, and skilled technicians. Moreover, supply-side limitations are also expected to affect adoption.

Moreover, a parliamentary panel in emerging countries has reportedly witnessed slow progress in the AI program due to limited semen production, limited availability of sex-sorted semen, and a shortage of trained professionals. These issues are further expected to challenge the market expansion, especially in rural areas where cold-chain infrastructure, veterinary access, and farmer awareness are still developing.

Segmentation Analysis

By Product

Higher Need for Kits & Consumables in Routine Procedures Boosted Segment Growth

Based on product, the market is segmented into equipment, kits & consumables, and others.

The kits & consumables segment accounted for the largest global veterinary artificial insemination market share in 2025. These are single-use or frequently replaced items, making them essential for routine AI procedures across dairy farms, beef farms, swine farms, equine breeding centers, and veterinary clinics. This is expected to support the segment’s growth during the forecast period.

The equipment segment is projected to grow at a 5.9% CAGR during the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Animal Type

Bovine Segment Dominated Due to Increasing Commercial Adoption of Bovine Semen

By animal type, the market is segmented into bovine, swine, ovine & caprine, equine, and others.

The bovine segment accounted for the largest market share in 2025. Bovine insemination has stronger commercial adoption than many other animal categories, as dairy and beef farms operate on a large scale and regularly invest in semen, breeding services, and fertility management. Moreover, the segment is estimated to hold a 53.9% share in 2026.

  • For instance, according to the data from the Observatory of Economic Complexity in February 2026, the U.S. recorded USD 19.9 million in bovine semen exports against USD 2.65 million in imports.

The swine segment is anticipated to grow at a 6.4% CAGR over the forecast period.

By End-user

Higher Usage of Artificial Insemination for Planned Breeding by Livestock Farms/Commercial Animal Farms Boosted Segment Growth

On the basis of end-user, the market is segmented into livestock farms/commercial animal farms, animal breeding centers & semen stations, and others.

In 2025, livestock farms/commercial animal farms dominated the market. They are primary users of artificial insemination for herd productivity, planned breeding, and genetic improvement. Moreover, these farms are using AI to reduce dependence on natural mating, lower disease transmission risk, improve breeding control, and increase the number of offspring from superior genetics. Such a scenario is anticipated to fuel demand for artificial insemination in livestock farms/commercial animal farms, propelling the segment’s growth. Furthermore, the segment is set to hold 44.1% share in 2026.

The animal breeding centers & semen stations segment is projected to grow at a 6.7% CAGR during the forecast period.

Veterinary Artificial Insemination Market Regional Outlook

Based on geography, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

North America Veterinary Artificial Insemination Market Size, 2025 (USD Billion)

To get more information on the regional analysis of this market, Download Free sample

North America accounted for the largest market share, valued at USD 1.01 billion in 2024 and USD 1.08 billion in 2025. The region benefits from the U.S. being both the largest exporter and a strong importer of animal semen, due to its highly developed dairy and beef cattle industries, the strong presence of livestock genetics companies, and advanced semen processing infrastructure.

  • For instance, according to data from the Observatory of Economic Complexity, the U.S. accounted for 47.0% of total Bovine Semen exports in 2024.

U.S. Veterinary Artificial Insemination Market

In 2026, the U.S. is anticipated to reach USD 1.01 billion, accounting for approximately 26.4% of global revenues.

Europe

Europe is projected to record a 5.3% growth rate during the forecast period, the second-highest globally, reaching USD 1.02 billion in 2026. Countries such as Germany, France, the Netherlands, the U.K., Italy, and Denmark have well-organized livestock breeding systems and strong demand for high-quality semen, which is anticipated to support their market expansion in the forthcoming years.

U.K. Veterinary Artificial Insemination Market

The U.K. market is projected to reach USD 0.13 billion in 2026, representing approximately 3.4% of global revenues.

Germany Veterinary Artificial Insemination Market

Germany's market is expected to reach USD 0.20 billion in 2026, accounting for approximately 5.3% of global revenues.

Asia Pacific

In 2026, the Asia Pacific market is projected to reach approximately USD 1.01 billion, making it the third-largest market globally. The growth is due to rising milk and meat consumption, government-backed breed improvement programs, and increasing adoption of sex-sorted semen in India and China.

Japan Veterinary Artificial Insemination Market

Japan is projected to generate approximately USD 0.08 billion in revenue in 2026, representing nearly 2.1% of global revenues.

China Veterinary Artificial Insemination Market

China’s market is anticipated to reach around USD 0.35 billion in 2026, accounting for nearly 9.2% of global revenues.

India Veterinary Artificial Insemination Market

India’s market is expected to reach approximately USD 0.24 billion in 2026, accounting for around 6.2% of global revenues.

Latin America and Middle East & Africa

Both Latin America and the Middle East & Africa are anticipated to witness moderate growth. The Latin America market is estimated to reach approximately USD 0.42 billion, and the Middle East & Africa market is set to reach USD 0.23 billion in 2026. Government livestock productivity programs, dairy modernization, and growing beef industries in these regions support the growth.

GCC Veterinary Artificial Insemination Market

In 2026, the GCC market is estimated to reach approximately USD 0.17 billion, representing around 2.1% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Strategic Initiatives by Key Players to Improve Their Market Positions

In 2025, ABS Global, Select Sires Inc., and STgenetics held the largest global market share. This share is attributed to a broad dairy and semen portfolio as well as a strong distribution network globally. Moreover, these companies differentiate their products through genetic quality, sex-sorted semen accuracy, and fertility performance.

Other key players are focusing on new product introduction and strategic initiatives to expand geographic reach. Moreover, these companies are moving beyond conventional semen toward premium solutions such as sexed semen and beef-on-dairy genetics, which are expected to enhance their market position in the upcoming years.

LIST OF KEY VETERINARY ARTIFICIAL INSEMINATION COMPANIES PROFILED

  • ABS Global (U.S.)
  • Select Sires Inc. (U.S.)
  • STgenetics (U.S.)
  • Semex Alliance (Canada)
  • URUS Group LP (U.S.)
  • Alta Genetics Inc. (U.S.)
  • CRV (Netherlands)
  • VikingGenetics (Denmark)
  • Cogent (U.K.)
  • IMV Technologies (France)

KEY INDUSTRY DEVELOPMENTS

  • August 2025: IMV Technologies launched next-generation ImaGo fertility scanners for field vets, supporting early pregnancy detection and herd management.
  • July 2025: Semex Alliance and NEOGEN entered into a partnership to deliver Semex Alliance’s Immunity Technology through NEOGEN’s Igenity Select genomic test for dairy producers.
  • June 2024: URUS Group LP, a company active in dairy and beef AI genetics, reproduction, and farm data systems, reached a partnership agreement with CVC Capital Partners plc to support strategic growth.
  • April 2024: IMV Technologies acquired Medivet Scandinavian AB, strengthening its animal reproduction and veterinary imaging
  • May 2023: IMV Technologies acquired Veterinary Solutions, a veterinary imaging company, to strengthen imaging tools used in reproductive management.
  • February 2023: Select Sires Inc. partnered with Zoetis Services LLC to help cattle producers gain more value from data through GeneNet
  • October 2022: Genus ABS, a part of ABS Global, announced a partnership with Ireland Genetics to distribute NCBC bulls in Great Britain.

REPORT COVERAGE

The veterinary artificial insemination market report presents a detailed assessment of each market segment, covering the major growth drivers, emerging trends, opportunities, restraints, and challenges shaping the industry. It also provides insights into technological innovations, key industry developments, market share analysis, and comprehensive profiles of leading companies.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 7.1% from 2026 to 2034
Unit Value (USD Billion)
Segmentation By Product, Animal Type, End-user, and Region
By Product 
  • Equipment
  • Kits & Consumables
  • Others
By Animal Type
  • Bovine
  • Swine
  • Ovine & Caprine
  • Equine
  • Others
By End-user
  • Livestock Farms/Commercial Animal Farms
  • Animal Breeding Centers & Semen Stations
  • Others
By Region
  • North America (By Product, Animal Type, End-user, and Country)
    • U.S. (Animal Type)
    • Canada (Animal Type)
  • Europe (By Product, Animal Type, End-user, and Country/Sub-region)
    • Germany (Animal Type)
    • U.K. (Animal Type)
    • France (Animal Type)
    • Spain (Animal Type)
    • Italy (Animal Type)
    • Scandinavia (Animal Type)
    • Rest of Europe (Animal Type)
  • Asia Pacific (By Product, Animal Type, End-user, and Country/Sub-region)
    • China (Animal Type)
    • Japan (Animal Type)
    • India (Animal Type)
    • Australia (Animal Type)
    • Southeast Asia (Animal Type)
    • Rest of Asia Pacific (Animal Type)
  • Latin America (By Product, Animal Type, End-user, and Country/Sub-region)
    • Brazil (Animal Type)
    • Mexico (Animal Type)
    • Rest of Latin America (Animal Type)
  • Middle East & Africa (By Product, Animal Type, End-user, and Country/Sub-region)
    • GCC (Animal Type)
    • South Africa (Animal Type)
    • Rest of the Middle East & Africa (Animal Type)


Frequently Asked Questions

Fortune Business Insights says that the global market value stood at USD 3.60 billion in 2025 and is projected to reach USD 6.65 billion by 2034.

In 2025, the market value in North America stood at USD 1.08 billion.

The market is expected to exhibit a CAGR of 7.1% during the forecast period of 2026-2034.

The kits & consumables segment led the market by product.

The key factors driving the market are the rising use of sexed semen and genetic improvement programs.

ABS Global, Select Sires Inc., and STgenetics are among the prominent players in the market.

North America dominated the market in 2025.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2021-2034
  • 2025
  • 2021-2024
  • 180
Download Free Sample

    man icon
    Mail icon
Jump to Content

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann